In Vivo Brain GSH: MRS Methods and Clinical Applications

• Main Authors: Francesca Bottino (Author), Martina Lucignani (Author), Antonio Napolitano (Author), Francesco Dellepiane (Author), Emiliano Visconti (Author), Maria Camilla Rossi Espagnet (Author), Luca Pasquini (Author)
• Format: Book
• Published: MDPI AG, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/antiox10091407; 2076-3921
• Keywords: glutathione (GSH); magnetic resonance spectroscopy (MRS); neurological disorders; Therapeutics. Pharmacology; RM1-950
• Source: Antioxidants, Vol 10, Iss 9, p 1407 (2021)

Glutathione (GSH) is an important antioxidant implicated in several physiological functions, including the oxidation−reduction reaction balance and brain antioxidant defense against endogenous and exogenous toxic agents. Altered brain GSH levels may reflect inflammatory processes associated with several neurologic disorders. An accurate and reliable estimation of cerebral GSH concentrations could give a clear and thorough understanding of its metabolism within the brain, thus providing a valuable benchmark for clinical applications. In this context, we aimed to provide an overview of the different magnetic resonance spectroscopy (MRS) technologies introduced for in vivo human brain GSH quantification both in healthy control (HC) volunteers and in subjects affected by different neurological disorders (e.g., brain tumors, and psychiatric and degenerative disorders). Additionally, we aimed to provide an exhaustive list of normal GSH concentrations within different brain areas. The definition of standard reference values for different brain areas could lead to a better interpretation of the altered GSH levels recorded in subjects with neurological disorders, with insights into the possible role of GSH as a biomarker and therapeutic target.